Skip to content

The Impact of Surgical Procedures on Postoperative Outcomes in Cataract Phacoemulsification and Analysis of Related Factors

The Impact of Surgical Procedures on Postoperative Outcomes in Cataract Phacoemulsification and Analysis of Related Factors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07550907
Enrollment
300
Registered
2026-04-24
Start date
2026-04-20
Completion date
2027-06-30
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related Cataract

Brief summary

The goal of this observational study is to evaluate the location of phacoemulsification tip measured by intraoperative OCT during cataract surgeries and its impact on early postoperative changes of cornea and visual acuity. The main question it aims to answer is: In patients with age-related cataracts undergoing phacoemulsification, does the location (supracapsular, iris-lens diaphragm, or endocapsular) of the phaco tip affect postoperative corneal changes and visual acuity at early postoperative stage? Eyes having phacoemulsification for cataracts will receive intraoperative OCT imaging to evaluate the location of the phaco tip during surgery, and corneal changes and visual acuity will be measured postoperatively.

Interventions

PROCEDUREcataract surgery

Cataract phacoemulsification combined with intraocular lens implantation

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 50 years and ≤ 90 years * Diagnosis of unilateral/bilateral age-related cataract * Nuclear grade ≥2 in LOCSIII classification * Scheduled for cataract phacoemulsification combined with intraocular lens implantation * Pupil size ≥6mm after dilation * Corneal endothelial cell count ≥1500 cells/mm²

Exclusion criteria

* Diagnosis of severe systemic disease (e.g., severe hypertension or Alzheimer's disease) * History of ocular trauma or surgery * Presence of other ocular diseases (such as glaucoma, diabetic retinopathy, or high myopia) * Other ocular factors that may complicate the surgery (such as small pupil, shallow anterior chamber)

Design outcomes

Primary

MeasureTime frameDescription
Change in corneal thicknesspostoperative day 1, week 1, and month 1Corneal thickness measured by corneal endothelial specular microscope

Secondary

MeasureTime frameDescription
Change in corneal endothelial cell density1 day, 1 week, and 1 month postoperativelyMeasured using corneal endothelial specular microscope
Best-corrected visual acuity1 day, 1 week, and 1 month postoperativelyMeasured using ETDRS visual acuity protocol with ETDRS visual acuity chart by a masked examiner
Intraoperative and postoperative complicationsIntraoperative, 1 day, 1 week, and 1 month postoperativelyMonitored by cataract surgeons using intraoperative OCT and postoperative slit-lamp examination. Complications include Descemet membrane detachment, posterior capsule rupture, incision leakage, and etc.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026